Sprague-Dawley rats |
Left external carotid artery permanently occluded and left internal carotid artery I/R (90 min/24 h) |
LA (50, 70, and 100 mg/kg, i.h) at 2 h before I/R |
Attenuating I/R injury via reducing oxidative stress and caspase-dependent apoptosis |
[94] |
Sprague-Dawley rats |
Middle cerebral artery selective I/R (30 s/30 s) before sustained I/R (2 h/24 h) |
LA (50 mg/kg i.p) for 30 min before I/R |
Exhibiting neuroprotection by attenuating neuroinflammation via inhibiting the TLR4/MyD88/NF-κB pathway |
[95] |
Sprague-Dawley rats |
Left middle cerebral artery I/R (2 h/1, 3, 7, 14, 21, 28, 35, 42, 49, and 56 d) |
LA injection (20 mg/kg) via the left external jugular vein immediately after I/R |
Exhibiting neurorestorative effects via insulin receptor activation, anti-inflammatory and antioxidant actions |
[96] |
Sprague-Dawley rats |
Ligating external carotid arteries and the internal carotid artery I/R (2 h/24 h) |
LA (10, 20,40, and 80 mg/kg) via the left external jugular vein after reperfusion |
Promoting functional recovery via attenuating oxidative damage mediated by the Nrf2/HO-1 pathway |
[97] |
Sprague-Dawley rats |
Right middle cerebral artery I/R (30 min/5.5 h) |
LA (0.05, 0.5, 5.0, or 50 mg/kg, i.v) at 30 min |
LA as a neuroprotectant via increasing protein expression of superoxide dismutase 2 |
[98] |
Sprague-Dawley rats |
Permanent distal middle cerebral artery occlusion-bilateral common carotid artery I/R (30 min/48 h) |
LA (40 mg/kg, i.p) at 30 min after ischemia |
Protective effects by LA via reducing phosphate mTOR |
[99] |
Albino rats |
Bilateral femoral arteries I/R (3 h/1d) |
LA (100 mg/kg, i.p) for 7 d after I/R |
Ameliorating neuronal damages, maintaining the normal structure, surface area, and the number of light neurons in the pyramidal layer |
[100] |
Mouse primary brain endothelial cell and bEnd.3 cell |
Oxygen glucose deprivation/reperfusion (6 h/4 h) |
LA (1 mM) pre- and posttreatment for ischemia |
Protecting against oxygen glucose deprivation/reperfusion injury via promoting the Akt/mTOR pathway |
[101] |
Sprague-Dawley rats |
Bilateral carotid artery I/R (30 min/24 h) |
LA (25 mg/kg, i.v) pretreatments |
Improving survival and protecting the rat brain |
[102] |
Gerbils |
Forebrain I/R (5 min/5 d) |
LA (20 mg/kg∗d, i.p) for 7 d |
Improving locomotor abilities and damages of the CA1 hippocampal pyramidal cells via antioxidant actions |
[103] |
C57blk mice |
Internal carotid artery I/R (45 min/24 h) |
LA (100 mg/kg, i.h)at 1.5 h before ischemia |
Reducing stroke infarct volume via antioxidant actions |
[104] |